By reaching the finals, these ten start-ups have already secured their space at ACHEMA 2022. You will have the chance to meet all of them in person and join in the award ceremony where the three overall winners be revealed.
Carbon Minds is a data analytics startup. It uses a proprietary digital model of the global chemicals and plastics industry to offer its clients transparency about environmental impacts in global supply chains.
Cenios is focused on development of next generation of POCT-Kits (Point-of-Care-Teste) for absolute quantification of analytes. The kits will be used as an alternative methods for therapeutic drug monitoring (TDM). The new products can reduce the cost and time of clinical measurements more than 100 fold in comparison to standard methods (HPLC or ELISA).
ESy-Labs GmbH is a pioneer in electrifying the chemical industry, developing processes for the electrosynthesis of organic chemicals based on high-throughput screening and artificial intelligence.
Lumatix Biotech seeks to improve the availability and affordability of antibody products by developing a light-controlled affinity matrix as a superior alternative to Protein A chromatography.
Phaidra creates AI-powered control systems for industrial processes. Its no-code software enables domain experts to specify which performance metrics they want to optimize, along with the operating parameters. Phaidra's reinforcement learning algorithms then determine and automatically implement the process setpoints that maximize plant performance.
PipePredict offers precise digital leakage localization, predictive maintenance and real-time monitoring of pipe networks by analyzing existing sensor data with a digital twin and AI algorithms.
PRAMOMOLECULAR has developed and applied for a patent for a particularly simple technology with which therapeutic oligonucleotides such as siRNAs can be transported efficiently and tolerably into the target cell in order to silence disease-causing proteins in the lungs, heart or pancreas. The pre-foundation project is thus developing drug candidates, e.g. against lung and pancreatic cancer.
The founding team of Pro-AspectX is developing a plug and play, non-invasive sensor to improve chemical, biotechnological and life science processes to highest possible efficiency, simultaneously raising the process safety by a forecast of critical situations
PROSION develops a first-in-class approach to address so far undruggable pharmaceutical targets that are linked with various hard-to-treat diseases through a disruptive platform of chemical building blocks called ProMs.
Semodia offers software solutions for the modularisation of the process industry, transferring the "Plug-&Play"-principle of office hardware via module type packages into the process industry.
60486 Frankfurt am Main
Tel.: +49 69 7564-100